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WIP1 PHAGE SPECIFICITY FOR B. ANTHRACIS

Sherry Kan, PhD
The Rockefeller University 2012

Bacteriophage-based diagnostics and therapeutics have been
recognized as tools to combat bacterial infections for nearly a century. Wip1 is
a recently isolated phage that infects Bacillus anthracis, the notorious biothreat
pathogen and gram-positive bacterium that causes anthrax disease. The
current standard for identifying suspected B. anthracis involves testing for Wγ
phage sensitivity. However, studies have shown that the narrow Wip1 host
range is even more specific to B. anthracis than that of Wγ, suggesting that
Wip1 may be a superior diagnostic tool.
Wip1’s high specificity to B. anthracis is likely mediated by the initial
recognition and binding of the virus to the host cell. Most bacteriophages
interact with bacterial surfaces using tail fibers, but Wip1 is a tailless phage
possessing an icosahedral protein coat covering an internal lipid membrane.
These features indicate that Wip1 belongs to the family Tectiviridae, a
relatively rare phage group with a proposed evolutionary lineage to the
mammalian adenovirus. Tectiviruses possess protruding spike complexes at
their vertices that are responsible for host recognition and binding.
	
  

	
  
Based on adsorption assays, we confirmed that Wip1’s host range
specificity is mediated by its receptor-binding ligand. In order to predict
candidate gene products for the Wip1 spike complex, we sequenced the Wip1
genome and conducted extensive genomic analyses with other tectiviral
genomes. Observations from subsequent recombinant Wip1 protein
expression and purification indicated that Wip1 p23 and p24 form a stable
complex. We identified the unique protein Wip1 p23 as a receptor-binding
protein using competitive inhibition and antibody neutralization assays. From
indirect immunofluorescence microscopy, we also demonstrated that Wip1
p23 binds very specifically to the surface of B. anthracis. Finally, we
characterized the bacterial receptor for Wip1 as a Sap-dependent cell wall
component.
The work in this dissertation has produced a significantly more detailed
understanding of Wip1’s highly specific tropism for B. anthracis. The findings
that we report here also demonstrate that Wip1 phage and its receptor-binding
ligand p23 are promising, new tools in the detection of B. anthracis.
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A.

LITERATURE REVIEW

1.

Introduction
Wip1 (for worm intestinal phage 1) is a recently identified phage that is

of great interest for two main reasons. First, Wip1 offers promise as a
biodefense tool. It is highly specific against Bacillus anthracis, the notorious
biothreat agent and gram-positive bacterium responsible for anthrax disease.
Host range analysis has demonstrated that Wip1 is even more specific for B.
anthracis than the current diagnostic standard Wγ phage [1]. Secondly, Wip1
belongs to the family Tectiviridae, a relatively rare and unusual group of phage
that shares a surprising evolutionary lineage with the mammalian adenovirus.
The tectiviral vertex spike complexes are of particular interest for both their
structural similarities to adenovirus vertex spikes and their role in host
recognition [2-4]. For these reasons, my dissertation focused on characterizing
Wip1 phage and, specifically, its vertex spike complex.
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2.

Bacteriophage
Viruses are obligatory parasites that depend on their host organisms to

support replication. Bacteriophage (“eaters of bacteria”), or phage for short,
are viruses that infect bacteria and have been reported for more than 140
bacterial genera [5]. Phages are estimated to be the predominant biological
entity in the biosphere [6]. They have been isolated from varied environments
including oceans [7], Artic sea ice [8], sewage [9], forest soil [1], and the
Sahara desert [10]. Phages have evolved to survive harsh conditions such as
extreme temperatures up to 95C in hot springs [11] and pH values as low as
1.3 [12].
Bacteriophage were originally discovered independently by Frederick
Twort in 1915 and Felix d’Herelle in 1917. After d’Herelle observed that phage
titers increased in stool samples from dysentery patients, he recognized the
possibility of using bacteriophage as therapeutics [13]. He isolated phages for
various bacterial diseases such as cholera, diphtheria, bubonic plague, and
anthrax. Many, but certainly not all, early phage therapy trials appeared to be
successful, leading to the manufacture and/or marketing of phage
preparations by d’Herelle’s laboratory in Paris (today known as L’Oreal) and
several pharmaceutical giants (Eli Lilly & Co, Parke-Davis, Squibb & Sons,
and Swan-Myers division of Abbott Laboratories, etc.) [13]. Unfortunately,
World War II and the discovery of penicillin diverted efforts away from the
further development of phage therapy in the United States and Western
Europe. Nonetheless, phage therapy trials continued in the former Soviet
2

	
  
Union and Eastern European countries, where phages are still regarded as a
viable therapeutic to combat bacterial infections.
Since their discovery, phages have been used as powerful model
systems in molecular biology. Phage research has led to many important
scientific discoveries [14]. For example, DNA was identified as the hereditary
material by Hershey and Chase in 1952 based on studies conducted using
bacteriophage T2. In another example, the study of RNA phages in the 1960’s
provided strong support for Crick’s postulated central dogma of molecular
biology that information flows from DNA to RNA to proteins. Phages have also
been used in practical applications such as phage therapy [13], phage display
[15], and diagnosis [16].
There are at least 13 distinct groups of phages classified by the
International Committee on Taxonomy of Viruses (ICTV) based on virion
morphology and nucleic acid composition. The three groups of dsDNA tailed
phages account for 96% of all reported phages in the literature. These three
groups differ in their tail morphology – long or short and contractile or noncontractile. The less common phage families exhibit tailless, polyhedral,
filamentous, or pleomorphic morphology [6] (Table 1).

3

	
  
Table 1. ICTV classification of bacteriophage
There are 13 families of bacteriophage classified by capsid morphology,
nucleic acid composition, and other characteristics such as presence of
a tail or an envelope.
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2.1

Tectiviridae
The family Tectiviridae (from the Latin tectus meaning covered)

includes phages possessing an icosahedral protein shell covering an inner
membrane bilayer containing a linear dsDNA genome. A relatively rare phage
group, the family currently consists of six isolates that infect gram-negative
bacteria and six that infect gram-positive bacteria. Gram-negative infecting
tectiviruses include PRD1 [9] and five closely related phages: PR3 [17], PR4
[18], PR5 [19], PR772 [20], and L17 [21]. Gram-positive infecting tectiviruses
include Bam35 [22], AP50 [23], phiNS11 [24], GIL01 [25], and GIL16 [26], and
Wip1 [1].
The majority of bacteriophages have a single central tail fiber that is
used to penetrate the bacterial cell wall and deliver the viral genome. In
contrast, tectiviruses are tailless and possess 11 labile vertices capable of
host binding and DNA delivery [3]. The twelfth vertex is proposed to play a role
in DNA packaging instead of receptor binding. All sequenced tectiviruses have
been shown to encode two different lytic enzymes. A proposed model
suggests that one lysin is a structural component of the virion active against
the peptidoglycan during genome delivery while the second lysin is
responsible for host cell lysis and progeny liberation following genome
replication and virion production [27].
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2.1.1 PRD1
PRD1 is the best characterized member of the Tectiviridae family and
infects a broad range of gram-negative bacteria including Escherichia coli and
Salmonella enterica [28]. The tailless, icosahedral, inner membrane-containing
phage possesses a 14,925 bp linear dsDNA genome with covalently linked
terminal proteins [9]. One-step growth experiments indicated that the latent
period was about 50 minutes and the burst size is roughly 500 infective
particles per cell [29]. The PRD1 virion measures 70 nm in diameter and its
genome shares approximately 98% sequence identity with other gramnegative infecting tectiviral isolates (PR3, PR4, PR5, and L17). Additionally,
PRD1 surprisingly shares many striking structural similarities to and a
proposed common evolutionary lineage with the mammalian adenovirus [30,
31]. Both viruses share a similar overall architecture, with comparably
structured capsid lattices and spike complexes at their vertices.
Through crystallization and mutagenesis studies, PRD1 proteins have
been fairly well defined. The capsid is stabilized by pentameric glue protein
P30 and hexameric major coat protein P3. Pentameric vertex protein P31
occupies each of the twelve vertices and forms the base of the spike complex.
Two elongated proteins, trimeric spike protein P5 and monomeric receptor
binding protein P2, form two separate spikes that protrude from P3 [2, 32, 33]
(Figure 1). The presence of P2 is dependent on P5, while both P2 and P5 are
missing in mutants lacking P31 [3].
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Figure 1. Model for the PRD1 spike complex shown from the side
The PRD1 spike complex is composed of pentameric vertex protein
P31, trimeric spike protein P5, and monomeric receptor-binding protein
P2. In this representation of the protein structures, one P5 monomer
(represented in red, purple, and blue), one P2 monomer (represented in
brown), and one P31 monomer (represented in orange) are modeled.
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The X-ray structure for receptor binding protein P2 resembles an
elongated sea horse with a distinct B propeller head and tail with a protruding
proline-rich fin (Figure 1). Receptor binding is likely to occur through the head,
which is distal to the virion. In one P2 model, the fin-shaped domain is
proposed to make initial contacts by scanning the host surface in order to
bring the head domain close to its receptor [4]. In another P2 model, the finshaped domain is suggested to interact with the rest of the spike complex.
Interaction of protein P2 with the receptor leads to a conformational
change that results in the dissociation of the metastable spike complex
proteins from the virion [32]. This is followed by the transformation of the
spherical internal membrane into a tube-like channel structure for the delivery
of viral DNA into the host [33, 34]. The genetic material is released into the
bacterial cell, while the empty phage capsid remains outside [35]. In P2mutants, tube-like channels spontaneously form and release DNA, indicating
that P2 is also responsible for stabilizing a metastable vertex structure [32].

2.1.2 Bam35
Bam35 is a tectivirus that infects gram-positive Bacillus thuringiensis
[22]. Based on negative-stain electron microscopy and electron cryomicroscopy with 3-D image reconstruction, the morphology of 73 nm Bam35
virions was shown to closely resemble that of PRD1 [36, 37] (Figure 2). Similar
tube-like membrane structures have also been observed for Bam35 upon host
8

	
  
binding [36, 37]. While wild-type Bam35 form turbid plaques, an isolate
designated Bam35c yielded clear plaques and higher propagation titers. The
14,935 bp linear dsDNA molecule of Bam35c is covalently linked to terminal
proteins. The Bam35c genome exhibits a similar organization and size as the
PRD1 genome, but no detectable sequence similarity [37]. On the other hand,
the Bam35 genome shares high sequence similarity with GIL01 and GIL16,
tectiviruses that also infect B. thuringiensis [25, 26, 38]. Genomic analysis
predicted 32 open reading frames (ORFs), all on the positive strand, in a
tightly packed organization with numerous overlapping ORFs [37].

Figure 2. Schematic of the Bam35 virion
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Bam35 gene products gp27, gp28, and gp29 have been identified as
candidate proteins for the spike complex. Genomic analysis of the
organizational location of ORF27 suggested that it is the vertex penton protein
of the spike complex. By threading Bam35 proteins onto PRD1 X-ray
structures, it was determined that gp28 is homologous to spike protein P5 and
that gp29 is homologous to the C-terminal half of receptor binding protein P2
[36, 37]. In addition, gp28 and gp29 were determined to reside on the surface
of Bam35 from phage aggregation and neutralization assays using polyclonal
antibodies [39]. However, competitive binding assays using both recombinant
and dissociated surface proteins were inconclusive and a Bam35 receptor
binding protein could not be identified.
Bam35 was found to rapidly adsorb to the peptidoglycan layer of the
host with signs of receptor saturation at an MOI of approximately 600 virions
per one cell [39]. Studies demonstrated that one of the two major sugar
components of the peptidoglycan, N-acetyl-muramic acid, neutralized the virus
and thus was proposed to be a receptor for the phage [39]. Upon host
adsorption, Bam35, like gram-negative infecting PRD1, displayed tube-like
membrane structures that are hypothesized to deliver the genome into the
cytosol. Based on electron microscopy, mature virus particles accumulate at
the center of the infected host at about 40 minutes post infection. Lysis occurs
at roughly 45 minutes post infection and takes 15 minutes to complete before
releasing roughly 39 infective particles per cell [37].

10

	
  
2.1.3 GIL01 and GIL16
GIL01 and GIL16 are both B. thuringiensis phages with similar
morphologies to other tectiviruses, characterized by a tailless, icosahedral
capsid measuring about 60 nm and containing an inner lipid membrane.
GIL01, an isolate from B. thuringiensis serovar Israelensis, shares 99%
sequence identity with Bam35, which was isolated from B. thuringiensis
serovar Alesti. Their genomes differ by only 11 bp and none of the mutations
significantly alter the genetic organization of either phage, suggesting that
GIL01 and Bam35 are virtually the same [26]. GIL01 shares 83.6% sequence
identity with GIL16, an isolate from B. thuringiensis B16. Studies showed that
GIL01 and GIL16 have slightly different host ranges. Interestingly, GIL01 does
not infect B. thuringiensis serovar Thuringiensis HER1047, a strain that is
susceptible to both Bam35 and GIL16 [26].

2.1.4 AP50
AP50 is a tectivirus isolated from soil in 1972 that specifically infects B.
anthracis. TEM analysis revealed a shell composed of two layers displaying
icosahedral symmetry and SDS-PAGE gels revealed nine major structural
proteins. Organic solvents such as chloroform and ether inactivated AP50,
confirming the phospholipid natures of the inner layer [40]. Burst size was
temperature dependent, with 200 to 300 particles per cell released at 25oC
and 37oC compared to about 3 to 5 particles per cell at 42oC. Originally
11

	
  
thought to contain RNA [23], it has now been determined to possess a 14,398
kbp linear dsDNA genome encoding 31 putative ORFs [41].
Wild-type AP50t produces turbid plaques, while the spontaneous
variant AP50c produces clear plaques. Interestingly, there exist only two
sequence changes between the two genomes. One mutation is located in the
non-coding region just upstream of ORF1. The other mutation is located within
ORF28, which has been designated a highly variable region of the genome
[41]. While Bam35, GIL01, and GIL16 share 86 to 99% sequence identity,
AP50c is less closely related to these other gram-positive infecting tectiviruses
with only ~53% overall percent identity.
Wild-type AP50t was shown in 1977 to have a very narrow host range,
infecting only one-third of the 34 B. anthracis strains and none of the 52 B.
cereus strains tested [42]. Recently, mutant variant AP50c was also shown to
be highly specific to B. anthracis in an even more extensive host range
analysis. 111 of the 115 B. anthracis strains and none of the 100 B. cereus
sensu lato strains were susceptible to AP50c infection [41].
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2.1.5 Wip1
Wip1 is a recently identified phage isolated from the intestinal tract of
Eisenia fetida earthworms in 2003 [1]. The earthworms were taken from forest
floor soil in Stroudsburg, Pennsylvania. Wip1 is a tailless phage with an
isometric head belonging to the family Tectiviridae (Figure 3) and produces
tube-like structures after adsorption or chloroform treatment [43].
Wip1 exhibits a very narrow host range and is highly specific to the
notorious pathogen B. anthracis. The current gold standard for identifying
suspected B. anthracis involves testing for Wγ phage sensitivity [16]. However,
using Wγ as a diagnostic tool can lead to false positives due to the
susceptibility of several Bacillus cereus strains to infection by this phage.
Recent studies have shown that the host range of Wγ is less specific to B.
anthracis than that of both Wip1 and AP50 [1, 41]. For example, B. cereus
strain ATCC 4342 is sensitive to infection by Wγ phage but not to infection by
either Wip1 or AP50. Additionally, the Wγ diagnostic phage yields plaques on
B. anthracis ∆Sterne only after 5 days, whereas Wip1 plaques can be detected
after just 12 hours post infection [1]. These advantages suggest that Wip1 may
be a superior diagnostic tool to Wγ.
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Figure 3. Comparison of Wip1 and Wγ phage morphologies
A. TEM of Wip1 phage. Scale bar = 25 nm
Wip1 phage belongs to the family Tectiviridae, characterized by a
tailless icosahedral protein capsid surrounding an inner lipid membrane.
The Wip1 vertex to vertex dimension measures about 60 nm.
B. TEM of Wγ phage. Scale bar = 50 nm
Wγ phage belongs to the family Siphoviridae, characterized by an
icosahedral head with sheathless, non-contractile, long tails. Wγ heads
measure 52 nm and their tails measure 185 nm long and 9.5 nm wide.

14

	
  
2.2

Adsorption
Specificity of a bacteriophage host range is often mediated by

specificity of adsorption. Receptor-binding proteins on the coat of the phage
interact very specifically with receptors exposed on the surface of the
bacterium. Since phage lack independent mobility, adsorption results from
random phage-cell collisions. It was suggested by Adam and Delbruck that
adsorption occurs in two stages [44]. In order to efficiently bind to a receptor,
which is small compared to the overall size of a cell, the phage particle first
finds the bacterial surface by 3D diffusion involving reversible binding to a
general recognition molecule. Once on the cell surface, the phage particle
then diffuses in a 2D fashion until it collides with a specific receptor, which it
binds to irreversibly. For the two-stage capture model to be advantageous, the
affinity between the host surface and the phage must be strong enough so
that the phage remains on the surface yet weak enough so that it can diffuse
across the surface [45]. While Adam and Delbruck’s theory assumed that all
collisions lead to binding, more recent studies have observed that that the
second irreversible binding step is surprisingly inefficient with only a small
fraction of the collisions leading to actual irreversible binding [46].

2.2.1 Bacteriophage receptor binding proteins
The adsorption of phages to the host receptors is mediated by receptorbinding proteins on the surface of the viral particle. Most receptor-binding
15

	
  
ligands are homomultimeric complexes that are involved with functions such
as cell wall penetration or DNA delivery in addition to host recognition. While
the domains that attach receptor-binding sites to the virion surface tend to be
well conserved among the members within a phage group, the receptorbinding domains are usually encoded in highly variable regions and tend to
display more sequence diversity.
The phages p2, bIL170, and TP901-1 are siphoviruses that infect the
bacterium Lactococcus lactis, used extensively worldwide for manufacturing
fermented milk products. The crystal structures of the receptor binding
proteins for these phages have been resolved. Despite lack of sequence
similarity and differences in host range within L. lactis, the three RBP
structures are remarkably close [47]. Each is postulated to be a homotrimer
located at the tip of their long, flexible, non-contractile tail and binds to
unknown surface saccharides [48]. Additionally, recent X-ray crystallography
studies showed that p2’s RBP also shares significant structural similarity with
siphovirus SPP1’s gp22 [49]. This viral protein is hypothesized to form the tip
of the tail of SPP1, a phage that infects Bacillus subtilis using receptor protein
YueB.
Podoviruses bind to cell hosts using stubby tail spikes attached to a
very short, non-contractile tail. Three to six tail spikes are required for
infectivity and the receptor-binding site is centrally located on the tail spike.
The tail spike of podovirus P22 is a stable homotrimer that exhibits both
binding and hydrolytic cleaving activity against Salmonella cell surface O16

	
  
antigen polysaccharide [50]. Another podovirus K1-5 has evolved to encode
two different tail spike proteins, one to bind type K1 and the other to bind type
K5 Escherichia coli strains [51]. Curiously, based on high sequence and
structural homology, it has been suggested that Podoviridae and Myoviridae
exchange receptor-binding domains [52].
E. coli phage T4 belongs to the family Myoviridae and adsorbs to the
host surface using both long and short tail fibers. First, the receptor-binding tip
of the long tail fibers reversibly interacts with lipopolysaccharides or outer
membrane porin protein C. Upon adsorption with at least three long tail fibers,
homotrimeric short tail fibers extend and irreversibly bind to the outer core
region of the lipopolysaccharides. The T4 long tail fibers are a complex of four
different proteins and possess a receptor-binding tip that is highly homologous
to the tip of the bacteriophage lambda side tail fibers [53].
PX174 is a tailless icosahedral phage with protruding adsorption spikes
consisting of five G proteins and one H protein. Protein G exhibits a
significantly higher affinity to E.coli lipopolysaccharide (LPS) than protein H
towards the same LPS. Spike protein G was also found to form a star-shaped
pentamer that provides a channel for DNA delivery. Lastly, studies showed
that protein G recognizes both the polysaccharide and lipid regions of gramnegative LPS [54].
Membrane-containing phages such as PRD1, PM2, and p6 bind to
receptors using spike proteins. Tectivirus PRD1 has two separate spikes,
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trimeric spike protein P5 and receptor-binding protein P2, protruding from its
vertices [2]. P2 is required for both adsorption and stabilization of the labile
spike complex. Corticovirus PM2 has a pentameric receptor-binding protein P1
occupying each vertex. The crystal structure of P1 revealed a Ca2+ ion bound
in a cleft at the tip of the protein that may mark the site of sugar binding [55].
Cystovirus p6 binds to its receptor using spike protein P3.

2.2.2 Gram-positive cellular receptors
The cell wall of gram-positive bacteria differs significantly from that of
gram-negative bacteria in both composition and structure. Gram-positive
bacteria typically lack an outer membrane and possess a considerably thicker
cell wall due to a thick peptidoglycan layer. Peptidoglycan is a heteropolymer
composed of sugars and amino acids that forms a cross-linked mesh-like layer
outside the plasma membrane. Gram-positive cells also have cell wall
glycopolymers attached to the peptidoglycan or cytoplasmic membrane, such
as teichoic acids, teichuronic acids, arabinogalactans, lipoteichoic acids,
lipomannans, and lipoarabinomannas. These cell wall glycopolymers
constitute the bulk of bacterial surface antigens and anchor the crystalline
surface layer (S-layer) proteins to the cell wall.
Phage receptors localized on the cell wall of gram-positive bacteria can
include peptidoglycan, teichoic acids, membrane-anchored proteins, or cell
wall-linked polysaccharides. N-acetyl-muramic acid, a major component of
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peptidoglycan, was identified as a component of the B. thuringiensis receptor
for tectivirus Bam35 [39]. Peptidoglycan was shown to bind to gram-positive
infecting phages sk1, jj50, and 64 [56]. Teichoic acid has been identified as
the B. subtilis receptor for bacteriophage SP50, but additional cell wall
constituents are also believed to be involved in the interaction [57].
Bacteriophages p25 and p29 attach to teichoic acid components, while
lactobacillus phages LL-H and JCL1032 adsorb to lipoteichoic acid elements
[58]. Teichoic acids are the surface component involved in initial reversible
binding of phage SPP1 to host cells, followed by irreversible adsorption to the
ectodomain of B. subtilis protein YueB [59, 60].
The B. anthracis receptor for Wγ phage was identified as LPXTG
protein GamR [61]. The protein receptor was discovered based on the
observation that sortase deficient B. anthracis was not as sensitive as the
parent strain to Wγ binding and infection. Interestingly, both Wγ sensitive B.
cereus ATCC 4342 and Wγ resistant B. thuringiensis 97-27 possess very
similar Gam-R like proteins with 89% and 96% homology, respectively [61].
Electron microscopy showed that Wγ phage bound to both strains [61]. These
observations revealed that GamR is sufficient for virion binding but not for
DNA delivery into B. thuringiensis 97-27. This suggests that there is a putative
second receptor necessary for DNA delivery, a cell wall component absent on
the surface of B. thuringiensis 97-27.
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3.

Bacillus anthracis
Bacillus anthracis is a gram-positive, rod-shaped, non-motile, spore-

forming bacterium with a width of 1-1.2 µm and a length of 3-5 µm. It can be
cultured in ordinary nutrient medium with iron sources under either aerobic or
anaerobic conditions. It is also one of the few bacteria known to synthesize an
antigenic capsule consisting of a poly-D-glutamate polypeptide. B. anthracis
was the first bacterium demonstrated to cause disease. In 1850, Rayer
described filiform bodies in the blood of animals dying from anthrax. In 1863,
Davaine showed that anthrax disease could be transmitted from animal to
animal by injection with infected blood. In 1877, Koch injected cultured B.
anthracis into animals and generated experimental anthrax disease. A few
years later, Pasteur successfully attenuated B. anthracis and used the
attenuated strains to vaccinate sheep against fully virulent strains.
B. anthracis is both genotypically and phenotypically similar to Bacillus
cereus, a ubiquitous soil inhabitant, and Bacillus thuringiensis, an insect
pathogen. The Bacillus family’s distinguishing feature is the production of
endospores, which are highly resilient, dormant, temporary structures formed
within the cells. These spores are cryptobiotic with no detectable metabolism.
B. anthracis spores are particularly durable and can survive environmental
stresses such as high temperatures, low-nutrient conditions, irradiation, strong
acids, disinfectants, and other harsh physical conditions for decades or
centuries.

20

	
  
Analysis of 16S and 23S rRNA has shown that B. anthracis has
remarkably close relationships with B. cereus and B. thuringiensis. The B.
anthracis 16S rRNA shares 100% sequence identity with that of B. cereus and
their 23S rRNA sequences differ by only two nucleotides. B. anthracis is also
very similar to B. thuringiensis, with only nine nucleotides differing between
their respective 16S rRNA sequences [62]. Notably, B. anthracis is even more
similar within itself. In fact, it may be one of the most molecularly homogenous
bacteria known with shared genetic similarities of over 90% between different
B. anthracis strains and isolates.

3.1

Anthrax disease
Bacillus anthracis is the causative agent of anthrax, a severe disease

that can infect any mammal, including humans. It predominantly infects
domesticated and wild animals, especially herbivores (including cows, sheep,
and horses). However, humans can become infected through contact with
diseased animals or as a result of bioterrorism. In the United States, there are
1-2 cases per year of naturally acquired anthrax in humans [63]. In September
and October of 2001, lethal B. anthracis spores were used to deliberately
contaminate envelopes sent through the mail. This bioterrorism attack led to
22 infections and five deaths from inhalation anthrax [63]. Today, the Center
for Disease Control and Prevention continues to classify anthrax as a highest
priority Category A agent with recognized biowarfare potential.
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B. anthracis can cause three types of infections: cutaneous,
gastrointestinal, and inhalational. A cutaneous infection, usually the result of a
cut or abrasion, is the most common and least dangerous infection type with a
mortality rate of less than 1% [64]. A gastrointestinal infection, usually the
result of eating infected meat or drinking contaminated water, is frequently
seen in carnivores. The inhalation of B. anthracis spores results in bacterial
germination and colonization of the host’s mediastynal lymph nodes. As the
capacity of the lymph nodes is exceeded, the bacteria enter the host’s blood
stream and cause septicemia. The most dangerous of the three types of
infection, B. anthracis inhalation is almost invariably fatal with a near 100%
mortality rate if not treated within 24-48 hours of contact [64].
The early clinical diagnosis of inhalation anthrax is extremely
challenging since the initial symptoms mimic that of influenza. Within 2-3 days,
patients progress from flu-like myalgias, fever, and malaise to dramatically
more severe symptoms such as dyspnea and hypoxemia, followed by
hypotension, hemorrhage, and death [65]. B. anthracis is susceptible to the
antibiotic penicillin, but resistant β-lactamase-positive strains have been
isolated. Alternative antibiotic drugs include ciproflaxin, erythromycin,
tetracycline, doxycycline, and chloramphenicol [65].
Fully virulent strains of B. anthracis harbor two endogenous plasmids,
pXO1 and pXO2. pXO1 encodes three toxins that are responsible for the
majority of pathology associated with B. anthracis while pXO2 codes for the
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protective capsule. The attenuated Sterne strain has only one plasmid pXO1
and the avirulent ∆Sterne strain has neither plasmid.

3.2

Bacillus anthracis detection
The dissemination of B. anthracis spores in a bioterrorist attack

continues to be a serious concern. A rapid, accurate, and sensitive detection
method would be a valuable tool for identifying whether B. anthracis is the
agent of an attack, especially because infection is difficult to diagnose and
anthrax has a high mortality rate. However, reliable identification of B.
anthracis is difficult due to its remarkable similarities to B. cereus and B.
thuringiensis.
B. anthracis can be identified using basic characterization assays. It is
sensitive to penicillin, non-motile, and not β-hemolytic on sheep or horse blood
agar plates. The current standard for B. anthracis identification is lysis by Wγ
phage. Originally isolated in 1955 by Brown and Cherry, Wγ was found to lyse
encapsulated smooth forms of B. anthracis but not any B. cereus strains that
were tested at the time. Later studies have identified two sensitive non-B.
anthracis strains, B. cereus ATCC 4342 and B. mycoides CDC680, as well as
two nonsusceptible B. anthracis strains [16]. Additionally, the Wγ lysin PlyG
was found to lyse B. anthracis is a highly rapid and specific manner and could
be developed as a tool to quickly detect germinating Wγ sensitive spores [66].
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Immunoassays using antibodies against B. anthracis spores, vegetative
cells, and toxin proteins have also been developed to detect B. anthracis.
Immunofluorescence systems, ELISA assays, and immunoradiometric assays
can detect spore surface antigens that are specific to B. anthracis using
immobilized spores. Some immunoassays, such as serological detection and
monoclonal antibodies against vegetative cell surface antigens, suffer from
cross-reactivity [67]. Others, such as sandwich-based antibody arrays and flow
cytometry to detect fluorescein-labeled antibodies to spores, have detection
limits. There are also enzyme immunoassays that detect anthrax toxins in the
blood, but these require the disease to have already progressed to an
advanced stage [67].
B. anthracis can also be detected using DNA-based assays. The United
States Postal Service had previously installed real-time PCR based anthrax
screening units at select sorting sites. PCR, real-time PCR, and multiplex PCR
techniques are based on amplification of B. anthracis specific DNA. Most
primers are designed to target sequences on either or both of the virulence
plasmids, pXO1 or pXO2. Studies have also identified a 277 bp region of the
chromosome that is conserved in 28 B. anthracis strains tested, but could not
be found in 33 heterologous bacteria strains [67]. However, this target is not
indicative of virulence and was later found in several B. cereus and B.
thuringiensis strains. Newer methods of DNA-based B. anthracis detection do
not require amplification steps such as PCR. Instead, the nucleic acid is
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detected using a sandwich-hybridization assay with a fluorophore-labeled
probe [67].

3.3

Bacillus anthracis surface layer
The B. anthracis cell wall differs from other gram-positive cell walls in

that they do not contain teichoic acid, a major cell wall component and popular
phage receptor in other gram-positive strains, and their surface layers are not
glycosylated. Furthermore, the cell wall contains carbohydrate residues that
are specific in composition to B. anthracis and different from that of even
closely related B. cereus strains [68]. Virulent B. anthracis also forms a poly-Dglutamate capsule. However, B. anthracis ∆Sterne, the strain mainly used in
this study, does not harbor the virulent plasmids and thereby does not possess
a protective capsule.
Bacterial S-layers are two-dimensional sheets of protein that selfassemble on the cell surface. In B. anthracis ∆Sterne, S-layers are the
outermost interaction zone with their respective environment (Figure 4). The
main S-layer proteins of B. anthracis are Sap and EA1, which are encoded by
the clustered genes sap and eag, respectively [69]. The gene csaB lies
adjacent to this operon, is responsible for the pyruvylation of the secondary
cell wall carbohydrates that S-layer proteins are anchored to, and is required
for the retention of S-layer proteins on the cell wall [70].
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Figure 4. Schematic of the B. anthracis ΔSterne cell wall
The cell wall of gram-positive B. anthracis ΔSterne has a thick
peptidoglycan layer composed of cross-linked sugars and amino acids. Major
components associated with the cytoplasmic membrane and peptidoglycan
include membrane lipoteichoic acids, cell wall proteins, and cell wall
polysaccharides. These associated glycopolymers anchor the crystalline
surface layer Sap and EA1 proteins to the cell wall. The B. anthracis cell wall
differs from other Bacillus strains in that it lacks teichoic acids and S-layer
glycosylation. B. anthracis ΔSterne lacks the plasmid that encodes the virulent
capsule.
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In B. anthracis, Sap and EA1 are sequentially produced under growth
phase control. Studies have suggested that an exponential phase Sap layer is
subsequently replaced by a stationary phase EA1 layer [71]. In part, this
regulation is due to recognition of the sap promoter by SigA, the housekeeping
sigma factor for RNA polymerase, and recognition of the eag promoter by
SigH, a transition state regulator that quadruples in concentration at the onset
of stationary phase [71]. This regulatory mechanism is highly flexible, as
shown by the observation that Sap is readily expressed if stationary phase
cells are resuspended in fresh medium.

4.

Objectives of the Study
The goal of this study was to develop a better understanding of Wip1’s

highly specific tropism for B. anthracis by studying the spike complex. We
started by imaging the morphological changes of Wip1 phage upon
adsorption, expanding its host range analysis with adsorption studies, and
sequencing its viral genome. Based on genomic analysis comparing the Wip1
genome with that of other gram-positive infecting tectiviruses, candidate gene
products for the Wip1 spike complex were predicted and used to identify a
Wip1 receptor binding protein that detects and exhibits specificity for B.
anthracis.
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B.

MATERIALS AND METHODS

1.

Bacterial strains and phages
The majority of bacterial strains in the present study have been

previously described [1, 43, 66]. All bacterial strains were grown in brain heart
infusion (BHI; Remel) broth or agar plates at 30oC according to standard
protocols. The bacteriophage Wip1 was isolated from the intestinal tract of
Eisenia fetida worms from Pennsylvania, USA. Phage propagation was
performed on the B. anthracis ∆Sterne strain.

2.

Phage propagation
High titer phage stocks were obtained by infecting stationary cell

cultures (100 µl) with 100 µl of a series of diluted (1:100 to 1:1000) Wip1
phage stocks. The phage-bacterium mixtures were incubated in a 37oC
waterbath for 15 min and then plated with molten top agar (0.8%) onto BHI
plates and incubated overnight at 30oC. When the viral plaques reached near
confluency, the soft agar overlays were collected in conical tubes, incubated
with 2 ml 10 mM K phosphate per plate for 15 min at room temperature, and
centrifuged at 4,000 rpm for 20 min at 4oC. The resulting supernatants were
filtered (0.45-µm-pore-size-filter) and stored at 4oC.
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3.

Phage purification scheme
High titer stocks of 1E9 – 1E10 PFU/ml Wip1 phage were produced and

filtered. Thee stocks were precipitated using PEG8000 and then concentrated
10X by centrifugation (Sorvall GS-3; 8,000 rpm; 30 min; 4oC). Phage pellets
were resuspended in 10 mM KPhosphate. Step gradients of CsCl layers were
overlaid with concentrated phage and centrifuged (Ti40 rotor; 22,000 rpm; 3 h;
4oC). Bands were extracted using both needle puncture and fraction removal
by pipette. Alternately, concentrated phage stocks were also overlaid on
continuous sucrose gradients of 20 – 70% that were centrifuged (Ti40 rotor;
22,000 rpm; 24 h; 4oC). Bands were extracted by pipette removal of fractions.
The gradient fractions containing the phage bands were dialyzed against 10
mM K Phosphate at 4oC and then titered on B. anthracis ∆Sterne to test for
activity.

4.

Transmission electron microscopy
Wip1 phage were incubated with overnight cultures of B. anthracis

∆Sterne at a MOI of 10 for 5 min at 37oC. After incubation, the mixtures were
transferred to a new microfuge tube with solidified agar on the bottom to act as
a cushion during the subsequent centrifugation at 6000 rpm for 3 min.
Supernatant was removed and the pellet was resuspended in 1x fixative. The
TEM analyses were then performed at The Rockefeller University Bio-Imaging
Resource Center as previously described [43].
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5.

Chloroform sensitivity assay
Wip1 phage samples (2 ml) were incubated with and without various

volumes of chloroform (up to 80 µl) in capped glass tubes with gentle mixing at
room temperature for 15 min. The mixtures were then titered on B. anthracis
∆Sterne. W2 phage with and without chloroform plated on B. cereus ATCC
4342 was used as a control.

6.

Phage adsorption assay
Various bacterial strains were grown to stationary phase (approximately

2 x 108 CFU/ml) and 100 µl of bacteria was mixed with 100 µl of Wip1 at 2 x
107 PFU/ml. The phage-bacterium mixtures were incubated in a 37oC
waterbath for 20 min and then pelleted at 7000 rpm for 3 min. The resulting
supernatants were subsequently spin-filtered (Millipore; 0.22 µm) and titered
on plates of B. anthracis ∆Sterne.

7.

DNA manipulation and sequencing
To obtain Wip1 DNA, Wip1 phage stock was lysed using NaOH and

then neutralized with Tris buffer and water. Tsp5091-digested restriction
fragments of mixed population were ligated to linkers, PCR amplified, and
inserted into TOPO vectors. After transforming these mixed plasmids into a
library of One Shot TOPO competent cells, uniform plasmid preparations were
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extracted and sequenced. Sequences derived from these transformed cells
were aligned to form a contiguous sequence using DNAStar Lasergene
Seqman Pro software. The final contig exhibited 11X average coverage and
was confirmed by sequencing PCR products generated directly from Wip1
phage DNA.

8.

DNA purification
In order to extract purified DNA from Wip1, high titer phage stocks were

first concentrated using direct centrifugation (UC 35K rotor; 30,000 rpm; 6 h;
4oC). The pellet was resuspended in 1/100 original volume of 10 mM K
Phosphate buffer. To remove viral coat proteins, 1/5 resuspension volume of
10% SDS and 1/5 resuspension volume of 10 mg/ml protease K were added
and the reaction was incubated at 55oC for 1.5 h. Organic solvents were then
used to disrupt the lipid membranes and separate phage DNA through 5X
phenol extractions followed by 2X chloroform extractions. The DNA in these
solutions was ethanol precipitated, washed in 75% ethanol, and finally
resuspended in 1/1000 original volume of ddH2O. The extracted DNA was
verified by PCR using primers specific to Wip1.
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9.

DNA-terminal protein analysis
To test for the presence of covalently linked terminal proteins, the

purified DNA was subjected to further protease K treatment followed by
multiple phenol and chloroform extractions, ethanol precipitation and washes,
and resuspension in ddH2O. The conditions for these steps are outlined
above in the DNA purification methods. DNA samples with and without this
second round of protease K treatment were analyzed using gel
electrophoresis.

10.

Lysogen induction assay
A lysogenic strain of B. anthracis ∆Sterne harboring a Wip1 prophage

was tested for induction by UV irradiation. Overnight cultures of the lysogen
were inoculated in BHI and grown to exponential phase for 3 h shaking at
30oC. These cells were pelleted and resuspended in 5 ml of 10 mM MgSO4
and transferred into an uncovered dish. This dish of cells was irradiated with a
254 nm lamp from above at a distance of about 10 cm for 10 seconds. The
cells were then incubated at 37oC shaking at 200 rpm for 15 min. Once again,
they were pelleted and resuspended in liquid BHI media. Phage induction was
allowed to proceed for 90 min at 37oC shaking at 200 rpm before culture
supernatants were recovered and filtered (0.45 µm). Filtered supernatants
from both irradiated and non-irradiated cells were titered on B. anthracis
∆Sterne in BHI plates.
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11.

Cloning of his-tagged Wip1 ORFs 22, 23, and 24
Standard molecular-cloning techniques were performed as described

by Sambrook and Russel. The PCR products containing the coding sequences
for the Wip1 gene products 22, 23, and 24 were separately amplified using
specific primers. Each DNA fragment was inserted into a modified CDFDuet-1
plasmid between the SalI-NotI sites preceded by a T7lac promoter and
ribosome binding site as well as two sets of His-tag sequences. Clones were
confirmed by sequencing using primers that flank the insert.

12.

Purification of his-tagged Wip1 p22, p23, and p24
Overnight cultures of E. coli DH5alpha cells carrying the cloned

constructs were diluted 1:100 and grown in LB medium with spectinomycin (20
µg/ml) for 4 h while shaking at 37oC. After being moved to 16oC, the cultures
were induced with isopropyl-b-D-thiogalactopyranoside (IPTG) at a final
concentration of 0.25 mM and shaken for an additional 18 h. Bacterial pellets
were collected by centrifugation (Sorvall SLC-6000 rotor; 7200 rpm; 30 min;
4oC) and resuspended in a cold buffer (50 mM Tris, pH 8.0 + 200 mM NaCl +
5 mM imidazole) at 1/100 of the original culture volume. Bacterial lysis was
conducted by multiple passages through a French pressure cell (at ~105 MPa)
at 4oC. The cell debris was removed by centrifugation (Sorvall SS-34 rotor;
8,000 rpm; 20 min; 4oC) followed by filtration (Nalgene; 0.45 µm).
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The following purification steps were conducted at room temperature
using buffers kept at 4oC. 25 ml columns were loaded with 1.25 ml bed volume
of Ni-NTA agarose (Qiagen) and equilibrated with 2x column volumes of buffer
(50 mM Tris, pH 8.0 + 200 mM NaCl + 5 mM imidazole). The cell lysate from
induced cultures was passed through the columns 2x using gravity flow. The
Ni-NTA agarose was then washed with 1x column volume of wash buffer A (50
mM Tris, pH 8.0 + 500 mM NaCl + 30 mM imidazole) and 0.5x column volume
of wash buffer B (50 mM Tris, pH 8.0 + 500 mM NaCl + 60 mM imidazole).
Finally, the eluate was collected by passing 5x bed volume of elution buffer
(50 mM Tris, pH 8.0 + 500 mM NaCl + 250 mM imidazole) through the column.
In preparation for the next step of the purification process, the eluted
proteins were dialyzed against buffer A (20 mM phosphate buffer; pH 7.4) at
4oC. Ion exchange chromatography was then conducted using a 5 ml HiTrap
Q HF column at a linear gradient from 100% Buffer A targeting 50% Buffer B
(20 mM phosphate buffer + 1 M NaCl; pH 7.4). Fractions containing the
purified proteins of interest were collected, analyzed with SDS-PAGE, pooled,
and dialyzed against 1X PBS at 4oC.
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13.

Cloning and purification of co-expressed his-p23 and p24
The cloning and purification schematic of his-p23 and p24 is exactly the

same as described for the individual recombinant proteins. The only difference
is that the PCR insert at the multiple cloning site began with the start codon for
ORF23 and ended with the last codon for ORF24. There are only 12 bp
separating the two ORFs. It should be noted that ORF24 was not cloned into a
separate site with its own promoter and tag.

14.

Inclusion body protein extraction
Overnight cultures of the clones carrying the recombinant constructs

were inoculated into BHI medium and induced with IPTG (0.5 mM final
concentration). Recombinant protein expression was allowed to proceed for 4
h shaking at 37oC before pellets were collected via centrifugation (Sorvall
SLC-6000 rotor; 7200 rpm; 30 min; 4oC). The cell pellets were completely
resuspended in room temperature BugBuster reagent, using 5 ml per gram of
wet pellet weight. The cell suspensions were incubated for 20 min rotating at
room temperature and centrifuged (Sorvall SS-34; 16,000 rpm; 20 min; 4oC).
The supernatants with soluble protein were saved for SDS-PAGE analysis.
The pelleted inclusion bodies were then resuspended in the same
volume of BugBuster reagent. Lysozyme was added at 200 µg/ml final
concentration and the mixture was vortexed and incubated at room
temperature for 5 min. 6 volumes of 1:10 diluted BugBuster reagent was
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added to the suspension before another vortex for 1 min. The suspension was
centrifuged (Sorvall SS-34; 16,000 rpm; 15 min; 4oC) and washed 3X in 1:10
diluted BugBuster. The final pelleted inclusion body fraction was resuspended
in PBS and analyzed using SDS-PAGE along with the soluble protein
fractions.

15.

Inhibition of phage infection
Overnight cultures of B. anthracis ∆Sterne (12 µl) were mixed with

molten soft agar (0.8%; 400 µl) and overlayed onto BHI agar plates measuring
35 x 10 mm. After letting the bacterial soft agar sit for 15 min, various dilutions
of the purified his-tagged phage protein stocks (PBS dilutions; 100 µl) were
evenly overlaid on top. The protein overlay was incubated atop the bacterial
agar for 15 min before a final overlay of Wip1 phage (~100 PFU) was evenly
added. Resulting plaques were counted at 48 hrs post infection. All steps were
conducted at room temperature.

16.

Inhibition of phage adsorption using polyclonal antisera against

his-p23
To generate polyclonal antisera against his-tagged Wip1 p23, 500 µg of
the purified protein was run on an SDS-PAGE gel and excised bands were
used as antigen to immunize 2 New Zealand white rabbits. Pre-immune serum
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was collected before the first immunization in complete Freund’s adjuvant and
for the second, third, and fourth immunizations in incomplete Freund’s
adjuvant. Immunizations and production bleeds were collected at 3-week
intervals for a total of 21 weeks.
The antisera were then tested for ability to inhibit Wip1 phage binding
activity. Various dilutions of serum (in BHI media) were mixed with Wip1
phage stock (~800 PFU) and incubated in a 37ºC waterbath for 30 min. After
adding 100 µl of overnight cultures of B. anthracis ∆Sterne, the serum-phagebacterium mixtures were incubated at room temperature for 30 min. Bacterial
pellets were collected via centrifugation at 12,500 rpm for 30 seconds,
washed, and resuspended in 10 mM K Phosphate buffer. Bacteria-bound
phage were plated onto BHI and proceeded to form plaques overnight. The
inhibition rate was measured as the percentage reduction of Wip1 PFUs as
compared to a no-serum, PBS control.

17.

Indirect immunofluorescence microscopy
The following protocol is a modified version of one previously described

[72]. Overnight cultures of various bacterial strains were inoculated at a 1:100
dilution in BHI media and grown to mid-exponential phase (unless otherwise
noted) by shaking for 3 h at 30oC. The cell cultures were then pelleted by
centrifugation (Eppendorf 5810 R; 4,000 rpm; 5 min; 4C), washed, and then
resuspended in PBS. To fix the cells, paraformaldehyde and NaPO4, pH 7.4
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were added to the suspension at final concentrations of 2.6% and 30 mM,
respectively. The cells were incubated for 15 min at room temperature,
followed by 30 min on ice, washed with PBS, and then attached to polylysinecoated glass cover slips. The fixed cells attached onto glass were then
washed with PBS and blocked with PBS containing 1% BSA for 15 min. The
cells subsequently underwent a series of 3 labeling steps: first with purified
his-tagged Wip1 protein, then with anti-His mouse antibodies, and finally with
anti-mouse rhodamine dye and 4’,6-diamidino-2-phenylindole (DAPI) strain.
Each labeling step consisted of incubating the cells with the labeling mixture
for 45 min in a moist chamber and was followed by thorough washes with
PBS. To reduce bleaching, the slides were mounted with 50% glycerol and
0.1% p-phenylenediamine in PBS pH 8.0. Images were captured using a
Delta-Vision image restoration microscope (Applied Precision/ Olympus)
equipped with CoolSnap QE cooled CCD camera (Photometrics). An Olympus
100x oil immersion objective was used in conjunction with a 1.5x optovar.

18.

Pull-down assay using his-p23 and Ni-NTA
Overnight cultures of B. anthracis ∆Sterne and B. cereus ATCC 4342

were inoculated in BHI media and grown to exponential phase by shaking for
3 h at 30oC. After being pelleted and washed in PBS, the cells were then
resuspended in PBS + 30% raffinose. PlyG lysin was added and the mixture
was incubated for 1 h at 37oC. The intact cell protoplasms were pelleted and
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the dissociated cell wall fragments remaining in the supernatant were removed
for use in the pull down assay. The following steps using Ni-NTA agarose
were conducted with the same buffers and conditions as the Ni-NTA
purification scheme previously outlined in this study. The Ni-NTA columns
were equilibrated and loaded first with purified his-tagged viral ligand p23 and
then with the cell wall supernatant. Multiple subsequent washes and elution
fractions were collected, concentrated with TCA precipitation, and evaluated
on SDS-PAGE gels.

19.

Phage adsorption assay using protease treated cells
Overnight cultures of stationary phase B. anthracis ∆Sterne and B.

cereus ATCC 4342 were pelleted, washed, and resuspended in either PBS,
PBS + pronase (1 mg/ml), or PBS + protease (1 mg/ml). After incubating the
cells for 1 h at 37oC, they were pelleted, washed, and resuspended in PBS.
Treated and untreated cells were then incubated with Wip1 phage for either 5
or 20 min at 37oC before spin filtration. The unbound phages in the filtrate
were titered using ∆Sterne and plated on BHI agar.

20.

Bacterial surface carbohydrate extraction
The following procedure was conducted over the course of

approximately one week with pellets frozen overnight each day. Overnight
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cultures of B. anthracis ∆Sterne and B. cereus ATCC 4342 were inoculated in
BHI media and grown for 6 h at 30oC. This culture was then used to inoculate
multiple liters of BHI media grown to stationary phase by shaking overnight at
30oC. Cells were collected via centrifugation (Sorvall SLC-6000 rotor; 7200
rpm; 30 min; 4oC) and washed multiple times with PBS before a final pellet
was frozen at -80oC. Frozen cells were resuspended in cold ddH2O using 1 ml
of water per 0.5 g wet weight of pellet. After lysis by passing 3X through a
French Pressure Cell at 15,000 – 20,000 psi, cell walls were separated via
centrifugation (Sorvall SS-34 rotor; 15,000 rpm; 30 min; 4oC). These cell wall
pellets were washed for a minimum of 6X with PBS ensuring vigorous
resuspension between each wash. The final pellet was resuspended again in
cold ddH2O using approximately 10 ml per 1.0 g wet weight of pellet.
To dissociate cell wall-anchored proteins, this suspension was slowly
added to a boiling solution of 2% SDS for roughly 15 min before cooling down
at room temperature for 30 min. Boiled cell walls were then sedimented via
centrifugation (Sorvall GS-3 rotor; 8,000 rpm; 40 min; 4oC) and washed at
least 4X with ddH2O to remove traces of SDS. Cell wall associated
carbohydrates were then separated using a hydrofluoric acid treatment. Cell
wall pellets resuspended in ddH2O were frozen in a vacuum tube using a dry
ice and ethanol bath before overnight lyophilization. For each 100 mg of
lyophilized cell wall product, 20 ml of 48-51% hydrofluoric acid was added
while stirring. This solution was first incubated at room temperature for 1 h
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without a cover and subsequently incubated at 4oC overnight with a secure
cover.
The next morning, the solution was centrifuged (Sorvall SS-34 rotor;
14,000 rpm; 10 min; 4oC) and the peptidoglycan-associated carbohydrates in
the supernatant were saved in a polypropylene container. Each 1 ml of
supernatant was treated with 5 ml of absolute ethanol and incubated at 4oC for
1 h. This solution was centrifuged (Sorvall GS-3; 8,500 rpm; 30 min; 4oC) and
the resulting pellet was then washed 3X with absolute ethanol (Sorvall SS-34;
16,000 rpm; 30 min; 4oC). The final polysaccharide pellet was left uncovered
at room temperature for 30 min to allow ethanol to evaporate before being
frozen at -20oC. Later, the precipitate was dissolved in cold ddH2O,
lyophilized, and stored at 4oC.

21.

Surface carbohydrate inhibition assay
The lyopholized surface polysaccharides from hydrofluoric acid

treatment were resuspended in ddH2O at a final concentration of 8 mg/ml.
Various titers of Wip1 phage stock (100 µl) were incubated with aliquots of the
extracted surface carbohydrates (100 µl) for 40 min in a 37oC waterbath.
Carbohydrate to phage ratios ranged from 0.8 mg carbohydrate sample per
100 PFU Wip1 to 0.8 mg carbohydrate sample per 100,000 PFU Wip1. After
incubation, the mixtures were titered on B. anthracis ∆Sterne using BHI plates.
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C.

RESULTS

1.

Wip1 morphology
Wip1 phage produced clear plaques on B. anthracis Sterne and

∆Sterne strains. Samples of the viral particles with and without the bacterium
B. anthracis ∆Sterne were analyzed by transmission electron microscopy.
Wip1 phage alone appeared as tailless, bilayer, icosahedral particles with a
vertex to vertex diameter of approximately 60 nm, similar in morphology to
other tectiviral phages.
Treatment with chloroform inhibited Wip1 activity, which is consistent
with Wip1 possessing an inner lipid membrane (Figure 5). A control phage
without a lipid membrane, W2, was not affected by chloroform treatment in its
infectivity against host strain B. cereus ATCC 4342. Interestingly, chloroform
treatment produced a 1.0 x 10-4 PFU/ml reduction in Wip1 infectivity but did
not completely eliminate activity. In contrast, tectiviruses Bam35 and GIL16
are completely disrupted by chloroform treatment. However, treatment with
organic solvents, such as chloroform and ether, for 30 minutes also inactivated
AP50 to a survival of about 1 x 10-4 PFU/ml [40]. It is suspected that this
characteristic indicates a different lipid composition from the others [73].
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Figure 5. Effect of chloroform treatment on Wip1 and W2 infectivity
Wip1 and W2 were tested for chloroform sensitivity by incubating phage
with chloroform for 15 minutes before titering on the respective host
strain. Wip1 exhibited inactivation while W2, which does not contain a
lipid membrane, did not.
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Upon incubation with its host B. anthracis ∆Sterne, Wip1 displayed a
tube-like structure (Figure 6) that has been described in other tectiviruses
including Bam35 and PRD1 [3, 22, 36]. In PRD1, interaction of protein P2 with
the host receptor leads to a conformational change that results in the
dissociation of the spike complex proteins from the virion [32]. This is followed
by the transformation of the spherical internal membrane into a tubular
channel structure for the delivery of viral DNA into the host [34, 74]. In some
cases, the Wip1 tube-like structures were seen to interact in a conventional
manner with the bacterial cell surface. However, interestingly, TEM images
captured several Wip1 phages with tube-like structures facing away from the
bacterial surface (Figure 6: B,C) instead of directly towards the host, a
phenomenon not observed in other tectiviruses [75]. This could indicate that
the labile vertex undergoing tubular transformation may not be the same as
the vertex that initially binds the receptor. This could also be explained by
reversible binding between the Wip1 tube-like structure and its host.
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A.

B.

C.
Figure 6. TEM images of Wip1 upon adsorption
Wip1 was incubated with B. anthracis ∆Sterne for 5 minutes at a MOI of
10 before being fixed for TEM imaging. Scale bar = 0.1 µ
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2.

Wip1 stability
Wip1 was tested for stability over time in different buffer conditions,

such as BHI (brain heart infusion), PBS (phosphate buffered saline), PM2
phage buffer (20 mM Tris-HCl, pH 7.2), SM phage buffer (50 mM Tris-Cl, pH
7.0; 0.1 M NaCl; 8 mM MgSO4; 5 mM CaCl2), and Bam35 phage KP buffer
(10 mM K Phosphate, pH 7.2). Results across the various buffers were similar,
with Wip1 retaining infectivity fairly well in each buffer. Bam35 phage
potassium phosphate (KP) buffer was selected as the standard Wip1 buffer in
all subsequent experiments for consistency.
High titer stocks of filtered Wip1 phage stored in 10 mM K Phosphate
buffer at 4oC exhibited higher stability over time than did Bam35 stored in the
same buffer. While Bam35 experienced a decay of infectivity of about 1 log
per 12 days [37], Wip1 experienced an approximately 1 log decrease in
infectivity per 60 days. Remarkably, Wip1 also retained its infectivity after
exposure to UV for up to 5 minutes and vigorous vortexing for up to 2 minutes
(data not shown). Experiments in this study that required serial dilutions of
Wip1 phage utilized vortexing for up to 30 seconds as a technique for rapid
and thorough mixing.
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Figure 7. Wip1 stability in various buffers
Wip1 was tested for infectivity over time in storage at 4oC in various
buffers: BHI (brain heart infusion broth), PBS (137 mM NaCl; 2.7 mM
KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4; pH 7.4), PM2 phage buffer
(20 mM Tris-HCl, pH 7.2), SM phage buffer (50 mM Tris-Cl, pH 7.0; 0.1
M NaCl; 8 mM MgSO4; 5 mM CaCl2), and KP buffer (10 mM K
Phosphate, pH 7.2).
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Wip1 lost infectivity during phage purification schemes that involved
either CsCl or sucrose gradients. Stepwise gradients using CsCl produced two
major bands, one at 1.3 g/ml and the second between 1.2 and 1.25 g/ml
(Figure 8). Continuous gradients using 20 – 70% sucrose normally produced
one major band between 60 – 70%, although one particular sucrose gradient
spin produced multiple bands (Figure 8). All bands were extracted by either
needle puncture or by fractionation and tested for phage activity.
Unfortunately, the particles recovered from the bands exhibited infectivity of
only 1 x 102 PFU/ml, a significant decrease from the original 1 x 1010 PFU/ml
stock used for the gradients. No infectivity was detected in any other fractions.
Similarly, CsCl gradients were also found to significantly decrease
Bam35 infectivity [37]. The high ionic strength environment was thought to
cause coat protein dissociation from the virion. Due to the observed
inactivation of phage, CsCl and sucrose gradient purification schemes were
abandoned. All subsequent experiments performed with Wip1 phage used
filtered high titer stocks in a solution of BHI/ 10 mM potassium phosphate, pH
7.2.
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A.

B.
Figure 8. Bands resulting from CsCl and sucrose gradients with Wip1
A. CsCl gradients
B. Sucrose gradients
CsCl and sucrose gradient purification of Wip1 phage produced visible
bands that were extracted. However, particles recovered from the
bands exhibited a 1 x 10-8 PFU/ml loss of infectivity from the original
titer. None of the other gradient fractions exhibited phage activity
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3.

Wip1 adsorption is specific to B. anthracis
Previous studies determined that Wip1 infectivity is more specific to B.

anthracis than is the standard diagnostic tool Wγ phage [1]. This host range
study was expanded to include both infectivity and adsorption of Wip1 virions
to various strains. Infectivity was measured by titering phage directly against
test strains on agar plates. Adsorption was assayed by incubating Wip1 with
test strains for 20 minutes, separating bacterium-bound phage via
centrifugation and filtration, and then titering the unbound phage in the
supernatant on B. anthracis ∆Sterne. The adsorption rate was calculated as
the percentage of bound Wip1 phage (# total phage – # unbound phage) out
of the total phage count (as determined by a buffer only control).
The narrow range of adsorption showed that Wip1 binding exhibited a
high specificity to B. anthracis that corresponded to its narrow infectivity host
range (Table 2). Wip1 exhibits high infectivity of 6 x 109 and a 100%
adsorption rate on host strain B. anthracis ∆Sterne. Similarly, Wip1 exhibits
infectivity of 3 x 107 and a 94% adsorption rate on B. cereus CDC32805. On
the other hand, Wip1 does not infect B. cereus ATCC 4342 and
correspondingly does not adsorb to it. These observations further support the
model of Wip1 tropism being mediated by the receptor binding proteins on its
surface.
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Table 2. Wip1 infectivity and adsorption range
Various bacterial strains were tested for Wip1 infectivity and adsorption.
The lower limit of detection of infectivity is indicated by “< 10”, while the
lower limit of detection of adsorption is indicated by “< 5”. The Wip1
host range is highly specific for B. anthracis in terms of both infectivity
and adsorption.
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Wip1 adsorption kinetics was studied by assaying the amount of bound
phage at various time points. As expected, B. cereus ATCC 4342 bound < 5%
of Wip1 phage, the lower limit of detection of adsorption. On the other hand,
stationary phase B. anthracis ∆Sterne bound approximately 80% of virus
particles during the first minute after phage adsorption and had adsorbed 99%
after 10 minutes (Figure 9). Bam35 experienced similar adsorption kinetics
with various B. thuringiensis strains. Strain 4I1 bound ~65% of phage in the
first minute and ~90% after 10 minutes, while strain HER1410 was found to
bind ~80% of virions in the first 20 seconds and 96% by 5 minutes [39]. Both
Wip1 and Bam35 adsorb very rapidly to their respective host cell surfaces.
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Figure 9. Wip1 adsorption kinetics
Wip1 was incubated with either B. anthracis ∆Sterne or B. cereus
ATCC 4342 for various lengths of time. Unbound phages were
separated via centrifugation and filtration before being titered on
∆Sterne. The adsorption rate was calculated as the percentage of
bound phage (total – unbound) out of total phage. Bars represent
standard errors of 6 experiments at MOIs from 1e-4 to 10.

53

	
  
4.

Wip1 DNA analysis
DNA was isolated from Wip1 phage by first denaturing the viral coat

proteins using protease K and SDS. After the denatured proteins were
removed by extraction with organic solvents phenol and chloroform, the DNA
was precipitated with ethanol and stored in buffer.
Based on DNA analysis, the Wip1 genome was determined to be a
linear molecule of dsDNA. Pulse field gel electrophoresis of purified Wip1 DNA
revealed a strong band estimated to be approximately 15 kbp (Figure 10). This
length is consistent with that of other tectiviruses, including Bam35c (14,935
kb) and PRD1 (14,925 kb). The double stranded nature of the DNA was
indicated by both band migration according to its sequenced length and
ethidium bromide (EtBr) staining. EtBr is a fluorescent tag that preferentially
intercalates double stranded structures of nucleic acids. Although it is possible
for EtBr to stain ssDNA, the signal is very weak. Serially diluted samples of
Wip1 DNA exhibited efficient EtBr staining indicative of dsDNA.
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Figure 10. PFGE of extracted Wip1 DNA
Pulse field gel electrophoresis migration of extracted Wip1 DNA was
analyzed along side 1Kb Plus, Low range PFGE, and Lambda Monocut
ladders.
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The extracted genomic DNA was tested for the presence of covalently
linked terminal proteins. DNA isolated from PRD1 and Bam35 was attached to
terminal proteins and could not properly enter an agarose gel, but protease
treatment allowed proper DNA migration [37]. In contrast, we observed similar
migration between Wip1 DNA treated with and without protease (Figure 11).
This observation suggested that, unlike the PRD1 and Bam35 genomes, Wip1
DNA is not associated with proteins.
However, the DNA extraction method was later re-evaluated for
potential removal of DNA-associated proteins even before the protease
treatment assay was conducted. It was originally thought that the Wip1 inner
membrane would protect its DNA from exposure to the protease step used to
remove coat proteins before phenol inactivation. But dissociation of the PRD1
spike complex protein P2 has been shown to promote tubular transformation
and DNA delivery [3]. It is possible that protease K digestion of the viral capsid
also leads to DNA release, which would expose the genome to protease
during the original DNA extraction. Due to this possibility, the protease
treatment assay was deemed to be inconclusive.
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Figure 11. Gel of Wip1 DNA with and without protease treatment
Extracted Wip1 DNA was treated with and without protease K before
subsequent purification using phenol/ chloroform extractions and
ethanol precipitation. Migration of the resulting DNA samples was
analyzed with agarose gel electrophoresis.
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5.

Wip1 genome analysis
Linker-mediated PCR amplification and shot-gun based sequencing

determined the Wip1 genome length to measure 14,319 bp. The closest
reported virus in the NCBI database in terms of genome size is AP50 with
14,398 bp. The average guanine-cytosine (GC) content of Wip1 is 36.9%,
which is lower than that reported of other tectiviruses such as Bam35c (39.7%)
and PRD1 (48.1%) [37]. We noted that the Wip1 genome GC content at both
extremities is lower than the percentage observed in the central section of the
genome. The first and last genes, ORF1 and ORF27, have GC contents of
29.5% and 29.7%, respectively. In contrast, ORF18 and OPF19, located at the
genome center, have GC contents of 43.1% and 44.8%, respectively (Table
3).
Detailed analysis of the Wip1 sequence revealed the existence of 27
putative open reading frames (ORFs), as listed in Table 3. The tightly
organized genome with few noncoding regions, small intergenic spaces, and
some overlapping ORFs is characteristic of its family Tectiviridae. Many of the
predicted genes are remarkably short, also similar to other tectiviruses. PRD1
has been shown to code for a protein as short as 42 residues (protein P20). In
comparison, the shortest predicted Wip1 genes are ORF1 and ORF11, each
with 47 predicted protein residues
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Table 3. Comparative analysis of predicted Wip1 ORFs with AP50,
GIL16c, and Bam35c ORFs
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Figure 12. Map of Wip1 genome and tectiviral genome analysis
60

	
  
Based on BLAST analysis and tectiviral genome organization, 14 out of
27 ORFs were designated putative functions. Wip1 encodes two different
lysins, ORF20 and ORF26, which are predicted to be a muramidase and an Lalanyl-D-glutamate peptidase, respectively. Interestingly, the N-terminal half of
ORF20 contains a conserved FlgJ domain. FlgJ is a Salmonella enterica
flagellar protein with peptidoglycan hydrolase activity that digests through the
peptidoglycan layer to facilitate rod penetration. BLAST analysis did not
identify any conserved domains for ORF26, but did indicate homology to
peptidases from B. cereus and Listeria.
While Wip1 exhibits some sequence similarities to gram-positive
infecting tectiviruses Bam35c and Gil16c, it is most closely related to AP50.
Wip1 and AP50 both exhibit very narrow host ranges highly specific to B.
anthracis [41]. The genome of Wip1 from ORF4 through ORF26 is strikingly
similar to the section of AP50 from ORF9 through ORF31 in ORF size,
sequence, and organization (Figure 12). Among the 27 total putative Wip1
ORFs, 20 share sequence identity of at least 50% to other tectiviral proteins
and 15 share high sequence identity of at least 75% to AP50 proteins.
The most remarkable distinction of the Wip1 genome is the placement
of the putative DNA polymerase, ORF27, at the 3’ end of the genome on the
negative strand. All other tectiviral DNA polymerases are encoded in the first
5000 base pairs of their genomes on the positive strand. In fact, Wip1 ORF27
is the only predicted gene found on the negative strand of any gram-positive
infecting tectivirus. While the putative ExoII, S/TLx2h, Kx2h, and ExoIII motifs
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of the 3’-5’ exonuclease domain were identified, the unusual sequence lacked
some of the more highly conserved motifs such as motif C or a clear ExoI
motif. Furthermore, the unusual Wip1 ORF27 gene product does not share
any significant homology with any other proteins in the NCBI database.
Another notable section of the genome involves the regulatory elements
located at the beginning of the sequence. Wip1 ORF3 was predicted to be a
LexA-type repressor based on BLAST homology. Despite its lack of sequence
similarity to tectiviral sequences, ORF3 surprisingly aligned with the genomic
position of Bam35 gp6, which is a LexA-type activator of late gene
transcription. BLAST analysis also suggested that ORF2 is involved in gene
regulation, which is particularly interesting since a LexA-type regulator
immediately follows it. Additionally, if the DNA polymerase is indeed regulated
by the phage itself, it would involve a regulator encoded at the beginning of
the genome acting upon the opposite extremity, a rare phenomenon in
phages. It should be noted that SOS-induction experiments using UV
stimulation did not induce lysogenic Wip1 virion production.
Yet another particularly intriguing region of the genome includes Wip1
ORF22, ORF23, and ORF24. Wip1 ORF22 is predicted to be a putative spike
complex protein as it shares 51.3% sequence identity with Bam35 gp28, a
homolog for PRD1 trimeric spike protein P5. Bam35 gp28 is followed by gp29,
a 293 amino acid protein that also resides on the phage surface. If Wip1 and
AP50 genomic organization both align with that of Bam35c, then a putative
spike complex protein should follow. Interestingly, in Wip1 and AP50, the
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genes downstream the P5 homolog are located in a highly variable region and
do not share sequence identity with any Bam35 ORFs. Despite the lack of
homology, we predicted that Wip1 gene products 23 and 24 (totaling 235
amino acids together) were putative spike complex proteins based on their
strikingly similar gene cassette alignment both upstream and downstream of
this region. Finally, we were intrigued by the observation that while Wip1
ORF24 shares 51% sequence identity with AP50 ORF29, Wip1 ORF23 is a
unique gene that does not share sequence homology to any other known
genes, tectiviral or otherwise.

6.

Wip1 p23 and p24 form a stable complex
Genomic analysis predicted three Wip1 proteins, p22, p23, and p24

(indicated in red in Figure 12) to be possible candidates for the Wip1 spike
complex. We developed expression and purification schemes for the histagged constructs of all three viral proteins. However, the separately
expressed his-p23 and his-p24 constructs resulted in extremely low yields of
soluble protein due to the formation of inclusion bodies (Figure 13). Curiously,
when his-p23 and p24 were co-expressed together, significantly higher yields
of soluble protein were generated, suggesting that his-p23 and p24 assist
each other in proper folding when co-expressed.
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Figure 13. SDS-PAGE of soluble and insoluble recombinant protein
fractions
Recombinant his-tagged constructs of viral proteins were built and
expressed using methods described. Induced cell cultures underwent
treatments to extract both soluble proteins and insoluble proteins from
inclusion bodies (using lysozyme, 14.7 kDa). Major bands for his-p23
(18 kDa) and his-p24 (18.8 kDa) are revealed in the inclusion body
extractions for each separate construct. In contrast, major bands for
his-p23 (18 kDa) and p24 (13.6 kDa) are visible in the soluble fraction
for the his-p23 + p24 co-expression construct.
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Subsequent recombinant protein purification steps also revealed hisp23 and p24 interactions. Nickel-nitrilotriacetic acid (Ni-NTA) resins are used
for rapid one-step purification of proteins containing a His-tag by preferentially
binding to histidine residues. After co-expressed his-p23 and p24 proteins
were processed through a stringently washed Ni-NTA column, both were
eluted together despite the fact that p24 was not his-tagged (Figure 14).
In a second purification step, the Ni-NTA elution was processed through
an ion exchange column that separates molecules based on their charge.
Distinct peaks were observed and analyzed by SDS-PAGE, revealing unique
protein populations in each peak. This indicates that ion exchange purification
was successful in separating proteins and protein complexes of different
charges. Again, both proteins were observed together in the same ion
chromatography fractions despite the fact that his-p23 and p24 exhibit
drastically different pIs of 8.4 and 4.9, respectively (Figure 14). The
observation that neither purification scheme separated the two proteins
strongly suggests that they form a stable complex.
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Figure 14. Ion chromatogram and SDS-PAGE of select fractions
The Ni-NTA eluate containing both his-p23 and p24 (Lane 1) was
further purified by charge using ion exchange chromatography. The
distinct peaks were evaluated with SDS-PAGE, which revealed the
presence of his-p23 alone in Peak 1 and the presence of his-p23 and
p24 together in Peak 2.
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Figure 15. SDS-PAGE of final stocks of purified recombinant Wip1
proteins
Following expression and purification methods as described, the
recombinant his-tagged Wip1 proteins were then measured using
standard BSA assays. Protein solutions were diluted to concentrations
of 250 µg/ml for single protein samples (his-p22; his-p23; his-p24) and
500 µg/ml for co-expressed protein samples (his-p23 + p24). SDSPAGE analysis of these protein samples revealed purification to near
homogeneity. The samples shown here are the exact samples used in
the following protein overlay-based inhibition assays.
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7.

Wip1 p23 is a receptor-binding protein
The purified recombinant proteins (Figure 15) were measured by

standard Bovine Serum Albumin (BSA) immunoenzymetric assays. Protein
stocks were diluted to concentrations of 250 µg/ml for single protein samples
(his-p22; his-p23; his-p24). The co-expressed protein complex sample (hisp23 + p24) was diluted to 500 µg/ml to account for the presence of two
different proteins. These recombinant protein stocks were then used in a Wip1
activity inhibition assay, which consisted of overlaying the viral proteins on top
of B. anthracis ∆Sterne growing in soft agar plates before adding a final
overlay of infectious Wip1 phage (Figure 16). The rate of infectivity inhibition
was calculated as the percentage of inactivated phage (# total original phage
– # infectious phage titered after incubation with recombinant protein) out of
total phage (as determined by a buffer only control).

Figure 16. Schematic of a Wip1 inhibition assay using recombinant Wip1
proteins
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His-p23 was shown to competitively inhibit Wip1 infectivity up to 100%
in a dose-dependent manner while his-p22 and his-p24 had no effect on
phage infectivity (Figures 17 and 18). This finding suggests that Wip1 p23 is a
receptor-binding protein. The addition of his-p23 would occupy the available
receptors on the host surface and prevent other ligands such as Wip1 phage
from binding. Interestingly, the his-23 plus p24 complex exhibited even higher
inhibition levels than his-p23 alone, a finding that may be explained by either
increased protein stability or enhanced activity of the receptor binding
complex.
The possibility that recombinant his-p22 and his-p24 may not possess
their full biological activity because of the linked histidine should be noted.
However, issues for his-p24 concerning potential misfolding or activity
interference caused by a histidine tag are partially addressed by the properly
folded and non-his-tagged p24 co-expressed with the his-p23 + p24 complex.

Figure 17. Photograph of Wip1 inhibition assay results
Results of the Wip1 inhibition assay using recombinant viral proteins at
a concentration of 125 µg/ml per protein.
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Figure 18. Wip1 inhibition of infectivity by recombinant Wip1 proteins
Wip1 phage was assayed for inactivation by recombinant viral proteins
at various concentrations. Protein concentrations are indicated per
protein. His-p23 (red) and the his-p23 + p24 complex (purple)
inactivated Wip1 infectivity by up to 100% in a dose-dependent manner.
His-p22 (blue) and his-p24 (green) did not affect phage activity. Bars
represent standard error for a minimum of 3 experiments.
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In a second Wip1 inhibition assay, we generated rabbit polyclonal
antisera against Wip1 his-p23. The resulting anti-his-p23 antibodies were
tested for neutralization of phage activity. Various dilutions of antibody serum
were pre-incubated with Wip1 phage before adding B. anthracis ∆Sterne
bacteria to the mixture. After centrifugation pelleted the bacterium-bound
phage, any unbound or antibody-bound phage remaining in the supernatant
was removed. The pelleted cells were plated to reveal the titer of bacteriumbound phage. Adsorption inhibition was calculated as the percentage of unadsorbed phage (# total phage - # bacterium-bound phage) out of total phage
(as determined by a buffer only control).
The anti-his-p23 antibodies reduced Wip1 adsorption by up to 90% in a
dose-dependent manner. Pre-bleed serum did not have an effect on Wip1
activity (Figure 19). This suggests that Wip1 p23 protein resides on the phage
surface and is consistent with the finding that it is a receptor binding molecule.
Anti-his-p23 antibodies would bind to p23 on the surface of Wip1 virions,
preventing the phages from binding to and infecting its host.
It should be noted, however, that the neutralizing effect of anti-his-p23
serum on Wip1 activity was much weaker compared to that of anti-gp28 or
anti-gp29 serum on Bam35 activity. At a mere 20x dilution, anti-his-p23
antibody inactivation measured below 20% (Figure 19). In contrast, anti-gp28
and anti-29 antibodies did not demonstrate phage inactivation rates below
20% until they reached dilutions of 5,000x and 100,000x, respectively [39].
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Figure 19. Anti-his-p23 antibody neutralization of Wip1 activity
Polyclonal antibodies were generated against his-p23 and tested for
neutralization of Wip1 activity using methods described. After preincubation with phage, anti-his-p23 (closed circles) inhibited Wip1
adsorption to B. anthracis ∆Sterne by up to 90% in a dose-dependent
manner. Pre-bleed serum (open circles) did not affect Wip1 adsorption
activity. Bars represent standard error of at least 3 experiments.
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One explanation for this difference is the possibility that his-p23 is a
poor antigen that generated a weak immunogenic response. To test this
possibility, an indirect ELISA assay determined that the polyclonal antisera
against his-p23 demonstrated reasonable immunogenic strength (reading of
Abs=1 at 1:2000 dilution). However, although the antisera was reactive
against recombinant his-tagged p23, it still may not exhibit the same level of
immunogenicity against non-his-tagged p23 on the Wip1 virion.
Additional observations led us to a second possible explanation. When
the serum-phage-bacterium mixtures were pelleted to remove unbound and
antibody-bound phage, the adsorption inactivation rate was ~80%. Yet, when
the serum-phage-bacterium mixtures were plated directly without pelleting, the
same concentration of anti-sera reduced infectivity by only ~40% (Figure 20).
From this finding, we hypothesized two possibilities: that Wip1 phage
association with the polyclonal antibodies is reversible and/ or that Wip1
phage has a higher affinity for its host receptor than for the polyclonal
antibodies generated against his-p23. In an assay with such kinetics, antibodybound phage plated with bacteria would disassociate from the antibodies over
time and preferentially bind to and infect its host instead. In contrast, plating
only the pelleted bacterium-bound phage would remove the population of
reversibly antibody-bound phage from the assay, allowing for greater
sensitivity.
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Figure 20. Comparison of anti-his-p23 serum neutralization of Wip1
adsorption and infection
Anti-his-p23 antibodies were tested for inhibition of both Wip1
adsorption (closed circles) and infection (open circles) using the same
serum dilution. While anti-his-p23 serum inhibited initial adsorption
(~80%), infectivity was inhibited to a much lesser degree (~40%). This
suggests that the effects of antibody neutralization become less
pronounced over time as phage dissociate from the antibodies and
preferentially bind to and infect their hosts.
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8.

Wip1 p23 binding is specific to B. anthracis
To further understand the interaction between Wip1 proteins and

bacterial surfaces, the purified his-tagged viral proteins were tested for surface
labeling of select bacterial strains using indirect immunofluorescence
microscopy. After adherence to a microscope slide, fixed bacterial cells were
first labeled with his-tagged recombinant viral proteins, then with anti-his
antibodies from mice, and finally with red-fluorescent anti-mouse antibodies
(Figure 21). Cells were also stained with 4’,6-diamidino-2-phenylindole (DAPI),
a blue-fluorescent stain that binds strongly to dsDNA.

Figure 21. Schematic of multi-step indirect immunofluorescence labeling
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Figure 22 illustrates that both his-p23 and the his-p23 + p24 complex
bind to the surface of B. anthracis ∆Sterne. These observations are consistent
with Wip1 p23’s function as a receptor-binding protein. Surprisingly, the
proteins bound all mid-log phase ∆Sterne uniformly but bound only a
subpopulation of stationary phase ∆Sterne. His-p22 and his-p24 were unable
to bind either phase of ∆Sterne, further suggesting that Wip1 p22 and p24 are
not involved with Wip1 adsorption. As expected, no Wip1 proteins bound the
surface of B. cereus ATCC 4342, which Wip1 neither infects nor adsorbs to.
In Figures 23 and 24, the specificity of the binding of his-p23 and the
his-p23 + p24 complex to B. anthracis is shown by additional indirect
immunofluorescence microscopy. The recombinant viral proteins successfully
bound B. cereus CDC32805, the only B. cereus strain in our host range
analysis that supported Wip1 infection and adsorption (Table 4). In contrast,
the his-tagged proteins were unable to bind the surface of B. cereus strains
CDC13100, CDC13140, ATCC 10987, and NRL 569. They were also unable
to bind B. thuringiensis strains HD1 and HD73. None of these unlabeled
strains support either Wip1 infection or adsorption. These findings suggest that
his-p23 does not bind to just any gram-positive bacterial surface, but binds
very specifically to the bacterial hosts that support Wip1 infection and
adsorption, including B. anthracis ∆Sterne.
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Figure 22. Indirect immunofluorescence microscopy using his-tagged
Wip1 proteins
1000X magnification
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Table 4. Comparative table of Wip1 host range and his-p23 binding
Bacterial strains that support Wip1 infectivity and adsorption showed
positive labeling by immunofluorescent his-p23 and his-p23 + p24
complex. Bacterial strains resistant to Wip1 activity were not labeled by
his-p23 or his-p23 + p24 complex. The lower limit of detection of
infectivity is indicated by “< 10”, while the lower limit of detection of
adsorption is indicated by “< 5”.
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Figure 23. Indirect immunofluorescence microscopy using his-p23 and
the his-p23 + p24 complex

1000X magnification
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Figure 24. Indirect immunofluorescence microscopy using his-p23 and
the his-p23 + p24 complex (cont’d)

1000X magnification
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9.

B. anthracis receptor for Wip1 requires Sap for cell wall presence
Based on Wip1 phage’s high specificity for B. anthracis, we

hypothesized that the cellular receptor for Wip1 is a cell wall component
unique to the surface of B. anthracis. Teichoic acids and S-layer
carbohydrates were not considered to be receptor candidates because they
are not present on the surface of B. anthracis [68]. The major repeating
peptidoglycan components were also eliminated as candidates because they
are universally present on all gram-positive bacteria and would not confer host
range specificity. In order to identify the cellular Wip1 receptor, we focused our
attention on cell wall associated proteins and carbohydrates.
Cell wall associated carbohydrates from B. anthracis ∆Sterne and B.
cereus ATCC 4342 were extracted and purified using a hydrofluoric acid
treatment as described in the Methods section. These surface carbohydrate
fractions were resuspended at a concentration of 8 mg/ml. To study the effect
of the carbohydrates on Wip1 activity, the carbohydrate samples were preincubated with various dilutions of phage before the mixtures were titered on
B. anthracis ∆Sterne (Figure 25). In this assay, carbohydrate to phage ratios
ranged from 0.8 mg carbohydrate sample per 100 PFU Wip1 to 0.8 mg
carbohydrate sample per 100,000 PFU Wip1. Phage infectivity was calculated
as the percentage of infectious phage out of total phage (as determined by a
buffer only control).
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Figure 25. Effect of surface carbohydrates on Wip1 infectivity
Extracted cell wall associated carbohydrates from B. anthracis ∆Sterne
and B. cereus ATCC 4342 were tested for their effect on Wip1
infectivity. Various dilutions of phage were pre-incubated with
carbohydrate samples before being plated out on ∆Sterne. Neither
carbohydrate fraction had an effect on Wip1 infectivity in this assay.
Bars represent standard errors of 4 separate experiments.
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Neither carbohydrate sample from the Bacillus strains demonstrated an
effect on Wip1 infectivity (Figure 25). However, these results do not
necessarily indicate that cell wall associated carbohydrates are not the Wip1
receptor. It should be noted that the carbohydrate extracts were not tested for
composition and could possibly lack purity that affected assay results.
Furthermore, it is very possible that the assay was not sensitive enough to
detect any inhibitory effect of the carbohydrate samples. In order for the assay
to detect competitive inhibition, there must be a high enough concentration of
receptors to occupy all 11 labile spikes on each Wip1 virion. The results of the
carbohydrate inhibition assay were thus deemed inconclusive.
In order to determine if the Wip1 receptor is a bacterial surface protein,
we studied the effect of bacterial protease treatment on phage adsorption.
Proteases (Pronase and protease K) were incubated with bacterial cells for 1
hour and then removed with multiple washes. Treated and untreated B.
anthracis ∆Sterne and B. cereus ATCC 4342 cells were incubated with Wip1
phage for 5 or 20 minutes before centrifugation and spin filtration. Unbound
phages present in the supernatant were titered on ∆Sterne. Bound phage was
calculated as the percentage of adsorbed phage (# total phage - # titered
unbound phage in supernatant) out of total phage (as determined by a buffer
only control). Adsorption rates measured over 99% for both protease treated
and untreated B. anthracis cells. The observation that protease treatment of
the bacterial surface had no effect on adsorption suggests that the Wip1
receptor is not a surface protein.
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Figure 26. Adsorption to protease treated bacteria
B. anthracis ∆Sterne and B. cereus ATCC 4342 were treated with and
without protease before subsequent washings and incubation with Wip1
phage. Adsorption was measured at 5 and 20 minutes post infection
time points. Results indicated no effect on adsorption from protease
treatment of cells. Bars represent standard error calculated from at
least three separate experiments.
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From personal communications, we learned that the closely related
phage AP50 does not infect B. anthracis SAP- mutants. SAP is the gene
encoding Sap protein, the 94 kDa B. anthracis surface array protein that forms
the S-layer during exponential growth [69]. The gene csaB lies next to the SAP
operon and is required for Sap protein retention on the cell wall. Wip1 was
tested for infectivity and adsorption on both B. anthracis Sterne SAP- and B.
anthracis csaB- strains. Infectivity was measured by directly titering Wip1
phage on bacterial soft agar plates. Adsorption was calculated as the
percentage of bound phage (# total phage - # unbound phage in supernatant)
out of total phage. Both mutants were resistant to Wip1 infection and
adsorption (Table 5). This finding indicates that the B. anthracis receptor for
Wip1 requires Sap protein for its presence on the cell wall.
Indirect immunofluorescence microscopy using his-tagged viral proteins
showed that his-p23 and the his-p23 + p24 complex were unable to bind B.
anthracis Sterne SAP- mutants (Figure 27). This is consistent with the
hypothesis that this mutant lacks the Wip1 receptor on its surface.
Table 5. B. anthracis Sap mutants do not support Wip1 infection or
adsorption
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Figure 27. Indirect immunofluorescence microscopy on B. anthracis
Sterne SAP- mutants using his-tagged Wip1 proteins
1000X magnification
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In order to test whether the Sap protein itself was the Wip1 receptor, we
performed a pull-down assay using receptor-binding complex his-p23 + p24 as
the affinity ligand. Cell wall associated proteins were extracted from mid-log
phase B. anthracis ∆Sterne and B. cereus ATCC 4342 by incubating the cells
with PlyG lysin in a 30% raffinose solution. While PlyG normally lyses Bacillus
cells, the 30% raffinose solution keeps the protoplasm intact, preventing the
release of cytoplasmic proteins into solution. After the protoplasms were
pelleted, the cell wall associated proteins in the supernatant were applied to a
Ni-NTA column pre-loaded with the receptor-binding complex his-p23 + p24.
Fractions from the column flow-throughs, washes, and elution were collected,
concentrated using TCA precipitation, and analyzed with SDS-PAGE.
Sap protein was revealed in fractions from mid-log phase B. anthracis
∆Sterne but not B. cereus ATCC 4342. However, the Sap protein was not
present in the elution, indicating that Sap did not bind to the receptor-binding
complex in the pull-down assay (Figure 28). Surprisingly, the elutions from
both ∆Sterne and ATCC 4342 pull-down assays contained two non-viral
proteins measuring between 30 to 40 kDa. However, these proteins were not
pulled down during the assay as they were revealed to be present in TCA
concentrated samples of purified his-p23 + p24 complex stock. Since the
recombinant proteins were expressed using E. coli cells, these two proteins
were not considered candidates for the B. anthracis specific cellular receptor
for Wip1.
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Figure 28. Pull-down assay using receptor-binding complex his-p23 +
p24
Cell wall associated proteins from mid-log phase B. anthracis ∆Sterne
and B. cereus ATCC 4342 were applied to Ni-NTA columns pre-loaded
with the receptor-binding complex his-p23 + p24. Fractions of the flowthroughs (F), washes (W), and elution (E) were collected and analyzed
with SDS-PAGE. 26 kDa PlyG (orange arrows) was used in the surface
protein extraction method. 94 kDa Sap protein (blue arrow) was
identified in ∆Sterne flow-through and wash fractions, but was not
eluted with the receptor-binding complex. The elution fraction revealed
two proteins between 30 - 40 kDa that were also present in the his-p23
+ p24 protein stock sample.
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The results of the pull-down assay strongly suggest that Sap protein is
not a receptor for Wip1 phage. The lack of proteins pulled down in the assay
was also consistent with the previous finding that the receptor is not a protein.
Although the cellular receptor for Wip1 has yet to be identified, it has been
thus characterized as a cell wall component specific to the B. anthracis
surface that requires Sap protein for surface availability.
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D.

DISCUSSION

Isolated relatively recently in 2003, Wip1 phage is the newest member
of the rare Tectiviridae family. Tectiviruses have been of particular interest due
to PRD1’s structural similarities to the mammalian adenovirus and AP50’s high
specificity for the biowarfare pathogen B. anthracis. Interestingly, Wip1 also
exhibits a narrow host range that is highly specific for B. anthracis, more so
than the current diagnostic standard Wγ phage [1]. In the present study, we
determined with adsorption assays that specificity to B. anthracis is mediated
by Wip1’s receptor-binding ligand. Here, we reported the unusual Wip1
genomic sequence and identified Wip1 gene product 23 as a receptor-binding
protein. We also showed that Wip1 p23 forms a complex with another viral
protein p24 and binds very specifically to B. anthracis. Ultimately, we
demonstrated that Wip1 is a unique phage and characterized the molecules
determining its host tropism.
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1.

Wip1 specificity for B. anthracis is mediated by specificity of

adsorption
Wip1 exhibits a highly specific tropism for B. anthracis and does not
infect closely related Bacillus strains such as B. cereus ATCC 4342. Although
tropism is often determined by receptor binding, this is not always the case.
For example, the poliovirus receptor is not sufficient to determine poliovirus
tropism to the brain and spinal cord since this protein receptor is produced on
a broad range of animal tissues. Instead, restriction of poliovirus replication is
thought to occur after viral binding and entry [76, 77]. In another case, electron
microscopy showed that Wγ phage binds to the surface of B. thuringiensis 9727, a strain that it does not infect [61]. This finding indicates that the Wγ
receptor GamR is sufficient for binding but not for DNA delivery.
By testing closely related Bacillus strains for Wip1 adsorption, we
demonstrated that Wip1 binding is very specific to B. anthracis (Table 2). This
strongly suggests that Wip1 specificity for B. anthracis infection is indeed
mediated by specificity of adsorption. Additionally, adsorption kinetics
indicated that Wip1 binding to its host surface is both specific and rapid. B.
anthracis ∆Sterne bound 80% of virus particles within one minute (Figure 9).
This rapid adsorption is also observed during Bam35 binding to B.
thuringiensis HER1410 [39]. However, given that the Bam35 receptor is a
major peptidoglycan component that dominates the cell surface, these kinetics
are less surprising for Bam35 than for Wip1.
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2.

Wip1 sequence exhibits both tectiviral genome conservation and

notable distinctions
We sequenced and examined the Wip1 sequence and determined that
it shares significant similarities to the genomes of other gram-positive infecting
tectiviruses. Its genome length of 14,319 bp is close to other tectiviral genome
lengths ranging from 14,398 bp (AP50) to 14,925 bp (PRD1). The map of
Wip1’s 27 putative ORFs reveal a tightly packed organization with short genes
and few noncoding regions, characteristic of all tectiviral genomes (Figure 12).
The Wip1 genome is predicted to encode a Lex-A-type regulator, five DNA
packaging/ assembly genes, a DNA delivery gene, two lysins, and at least four
capsid/ spike genes. The size, sequence, and/ or organization of these ORFs
are remarkably similar to that of other gram-positive infecting tectiviruses.
Wip1 is most closely related to B. anthracis specific phage AP50, with 15 out
of 27 ORFs sharing sequence identity of at least 75% to corresponding AP50
genes.
While the central section of the Wip1 genome exhibits some
conservation to other tectiviral genomes, the extremities displayed highly
unusual features. This was rather unexpected considering that all other grampositive infecting tectiviruses exhibited significant conversation throughout the
entire lengths of their genomes. In fact, Bam35, GIL01, and GIL16 share 86 to
99% sequence similarity. In contrast, Wip1 is missing the first 5 conserved
ORFs and has replaced them with unique genes for ORFs 1 through 4. Most
interestingly, Wip1 encodes its DNA polymerase at the very end of its genome
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on the negative strand whereas all other tectiviruses including PRD1 encode
its polymerase early in the sequence on the positive strand. Furthermore,
many of these genes are not only unique within the group but also unique
within the entire known database of proteins.
Notably, the GC content at both extremities is lower than the
percentage observed in the central region of the genome and more precisely,
in all the ORFs that share homology with AP50 (Table 3). The 5’ end of the
Wip1 genome encodes ORFs 1 through 4, which have GC contents of 29.5%,
30.7%, 25.7%, and 25.7%, respectively. The opposite 3’ end encodes ORF27
which has a GC content of 29.7%. In contrast, the genes located at the center,
such as ORF18 and ORF19, have GC contents of 43.1% and 44.8%,
respectively. Intergenic spaces at the extremities are also larger than those at
the central section of its own sequence and what is observed for other
tectiviral genomes. These observations point to the possibility of a different
origin for the genome extremities of Wip1. The combination of conservation
and deviation exhibited could indicate that Wip1 is an evolutionary hybrid
between AP50 and something else with significant differences.
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3.

Wip1 receptor-binding ligand p23 is a unique protein
The identification of Wip1 p23 as a receptor binding protein is very

interesting because it is a unique protein with no homology to any other known
proteins. It is particularly surprising because ORF23 shares no sequence
identity with AP50, a closely related tectivirus with a similar host range that is
also highly specific to B. anthracis. Genomic analysis showed that the overall
Wip1 genome shares significant similarities to the AP50 genome in ORF size,
sequence, and organization. In fact, the genes neighboring Wip1 ORF23
display this conservation. ORF22 (291 residues) shares 84% sequence
identity with AP50 ORF27 (304 residues) and ORF24 (118 residues) shares
51% sequence identity with AP50 ORF29 (118 residues).
Another interesting observation is that AP50 ORF28, which is located in
the corresponding genomic position to Wip1 ORF23, is the gene that harbors
one of two sequence mutations that differentiate isolates AP50t, which
produces turbid plaques, and AP50c, which produces clear plaques [41].
Generally, clear plaques are formed when the host is completely susceptible
to the phage while turbid plaques are formed if the host is partially resistant to
the phage (e.g. if 10% of the cells survive infection). The other mutation is
located in the non-coding region upstream of ORF1. Furthermore, AP50
ORF28 and Wip1 ORF23 are located at a highly variable region of their
respective genomes. On the one hand, it is not too surprising that the Wip1
receptor-binding domain ORF23 exhibits sequence diversity. On the other
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hand, it is rather unusual that two closely related tectiviruses with a similar
host range have evolved uniquely different receptor binding proteins.

4.

A proposed function for Wip1 p24
A notable observation is that the his-p23 + p24 complex exhibited

higher competitive inhibition than his-p23 alone (Figure 18), suggesting that
p24 somehow complemented or enhanced his-p23 binding activity. This
enhancement could result from simply protecting his-p23 proteins from
degradation. However, we were careful to use fresh protein stocks in the
assay. Considering that the inhibition rate of his-p23 was dose-dependent, the
increased inhibitory activity from the complex sample could simply result from
higher amounts of the his-p23 protein. However, SDS-PAGE analysis of the
recombinant protein stocks used in the assay (Figure 15) showed that this was
not the case.
Another more interesting possibility is that p24 plays a secondary but
complementary role in Wip1 binding. The adsorption of phage to the grampositive bacterial surface has been suggested to occur in two stages. The first
step involves reversible binding to general recognition molecules on the cell
surface. This weak interaction allows the virion to stay close to the bacterial
surface while diffusing across space. The second step involves colliding with a
specific receptor in an irreversible manner. The seahorse-like structure for
PRD1 receptor-binding protein P2 consists of multiple domains with different
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purported functions [4]. In one P2 model, the fin-shaped domain is proposed
to make initial contacts by scanning the host surface in order to bring the
receptor-binding domain closer to its receptor. It is possible that Wip1 p24 is
such a spike complex domain with non-specific, reversible surface scanning
properties.

5.

Considerations regarding the Sap-dependent cellular receptor
The inability of Wip1 phage to adsorb to or infect B. anthracis Sterne

SAP- and csaB- mutants indicated that the cellular receptor requires Sap
protein on the cell surface. The SAP gene encodes the Sap protein and the
neighboring csaB gene is involved in anchoring Sap protein to the cell wall.
The observation that Wip1 binding is Sap dependent led to many questions.
First, we wondered about Wip1 adsorption to and his-p23 binding to
stationary phase B. anthracis ΔSterne cells. In B. anthracis, Sap decorates the
bacterial surface only during exponential growth and is subsequently replaced
by S-layer protein EA1 upon entering stationary phase [71]. Adsorption assays
were conducted using stationary B. anthracis ΔSterne cells and, yet, we
observed rapid adsorption of 80% of virions after one minute and up to 99%
after 10 minutes (Figure 9). Similarly, indirect immunofluorescence microscopy
showed his-p23 binding to fixed stationary phase ΔSterne (Figure 22).
Interestingly, the viral ligand was only able to bind to a subpopulation of
stationary phase ΔSterne but was able to bind all mid-log phase ΔSterne.
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Additionally, the signal from his-p23 labeling was noticeably stronger for midlog phase ΔSterne than for stationary phase cells.
The ability of stationary phase B. anthracis lacking Sap protein to
adsorb the Wip1 receptor-binding ligand could possibly be explained by the
highly flexible regulatory mechanism of SAP and ea1 expression. Although
Sap is replaced by EA1 during stationary phase, it was also observed that Sap
is readily expressed as soon as stationary phase cells were resuspended in
fresh medium [71]. It should be noted that while the indirect
immunofluorescence microscopy methods involved cell washing before
fixation, the adsorption assay did not involve any wash steps, only the addition
of propagated phage stored in a mixture of BHI media and buffer. As flexible
as sap regulation may be, it remains curious that unwashed stationary B.
anthracis cells were observed to adsorb 80% of virions in one minute.
A second question we wondered was whether Sap protein itself was the
actual receptor. Although the protease treatment assay seemed to suggest
that the receptor was not proteinaceous in nature, the new considerations
regarding the rapid production of Sap made this assay inconclusive. However,
Sap protein extracted from the surface of mid-log phase B. anthracis ΔSterne
did not exhibit affinity to the receptor-binding complex in the pull down assay.
While the protease assay was deemed inconclusive in light of new
observations, the pull down assay results still indicated that Sap was not a
receptor for the Wip1 his-p23 + p24 complex.
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A third question we asked was regarding the nature of the Sap
dependent receptor. Curiously, the S-layer for B. anthracis is not decorated
with carbohydrate residues and Sap layer-associated proteins have not been
described. While the receptor has yet to be identified, it would be very
interesting indeed to characterize a B. anthracis-specific cell wall element that
requires Sap protein for availability on the cell surface.

6.

Wip1 phage potential as a diagnostic tool for B. anthracis
The Wip1 phage and its receptor-binding ligand exhibit promise as bio-

defense tools in the detection of the Category A pathogen B. anthracis. We
demonstrated that not only does Wip1 infect B. anthracis with high specificity,
but it also binds to its surface in a manner that is remarkably rapid and exhibits
high affinity. Indirect immunofluorescence microscopy demonstrated that the
Wip1 receptor-binding p23 and the p23+p24 complex detect and bind B.
anthracis with specificity that seems to match its narrow host range. In addition
to high specificity, we propose that the receptor-binding p23 exhibits higher
affinity for its receptor than to even polyclonal antibodies generated against it.
These characteristics that we report here make Wip1 and its receptor-binding
ligand potentially useful diagnostic tools for B. anthracis.
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